- Hu Shanlian, Professor, Fudan University School of Public Health
- Chen Wen, Professor, Fudan University School of Public Health
- Chen Xiaoming, Professor, Fudan University School of Public Health
- Chen Xinbao, Professor, Fudan University School of Public Health
- Ye Lu, Professor, Fudan University School of Public Health
- Yin Xiaohua, Professor, Fudan University School of Public Health
- Liu Bao, Professor, Fudan University School of Public Health
- Chen Yingyao, Professor, Fudan University School of Public Health
- Ye Ye, Professor, Shanghai School of Pharmacy
- Zhou Ting, Shanghai Academy of Social Sciences
- Jin Caihong, Shanghai Academy of Social Sciences
- Hu Huanting, Director, Chinese Health Resources Journal
- Jing Qing, Shanghai Jiaotong University School of Public of Health
- Yu Wei, Shanghai University of Finance and Economics
- Zuo Xuejiin, Shanghai Academy of Social Sciences
- Cao Junshan, Deputy Director, Shanghai Labor and Social Security Bureau Medical Insurance Dept
- Gu Yuanyuan, Director, Shanghai Municipal Medical Insurance Management Center
- Wu Long, Director, Shanghai Municipal Medical Insurance Bureau
- Pen Yumei, Deputy Director, Shanghai Municipal Public Health Bureau Law and Policy Dept.
- Zhang Runwei, Shanghai Municipal Food and Drug Administration General Office
- Yu Guanjun, Deputy Director, Shanghai Shenkang Hospital Development Center
- Yan Fei, Director of Healthcare Economics, R&D-based Pharmaceutical Association Committee (RDPAC)
- Shun Jing, Eli Lilly, Shanghai
- Zhu Hao, Eli Lilly, Beijing
- Zhu Ning, GSK China
- Zhou Wenyan, Medical Scientist, GSK China
- Zheng Wei, Manager, Medical Dept., GSK China
- Hua Ling, GSK China
- Alison Tan, GSK China
- Sheng Feng, GSK China
- Lu Xianzhong, GSK China
- Yang Jian, Government Affair Manager, Wyeth Shanghai
- Li Mei, Manager, Clinical Research, Wyeth Shanghai
- Gao Tong, Director, Medical & Public Affairs, Roche Shanghai
- Shi Rongrong, Manager, Medical Dept., Roche Shanghai
- Yu Yue, Roche Shanghai
- Zhang Fenghua, Roche Shanghai
- Rou Xiaoxia, Roche Shanghai
- Kang Zhiqing, Director, Medical Dept., Pfizer Shanghai
- Fong Danlong, Director, Corporate Affairs, Pfizer Shanghai
- Zou Jiansheng, Manager, Media Affairs, Pfizer Shanghai
- Chen Yuping, Manager, Medical Insurance, Pfizer Shanghai
- Bao Feng, Manager, Media Affairs, Pfizer Shanghai
- Sun Yufong, Outcomes Research Advisor, Pfizer Shanghai
- Sun Yuebo, Government Affair Manager, Fuxing Mecica and Pharmacetical Corporation
- R Abdula, Manager, Medical Information, Novonordisk China
- Guo Zhiming, Manager, Government Affairs, Genzyme Shanghai
- Luo Yiping, Navartis Beijing
|
